ArticleNPJ primary care respiratory medicine2018
"Tossing a coin:" defining the excessive use of short-acting beta
Article in NPJ primary care respiratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites.NPJ primary care respiratory medicine · 2024Article
- The Association Between Short-Acting βAdvances in therapy · 2024Observational
- A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024Article
- Article
- It is time to end our love affair with short-acting βERJ open research · 2022Article
- High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma.Journal of asthma and allergy · 2021Article
- Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician.The World Allergy Organization journal · 2019Article
- Welcome new guidelines: Now the hard work starts!Annals of thoracic medicineArticle
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The National Review of Asthma Deaths (NRAD) identified high prescribing of short-acting beta
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.